US revokes emergency use of drugs touted by Trump vs. virus
WASHINGTON (AP) — U.S. regulators are revoking emergency authorization for malaria drugs promoted by President Donald Trump for treating COVID-19.
The Food and Drug Administration said Monday that the drugs hydroxychloroquine and chloroquine are unlikely to be effective in treating the coronavirus. Citing reports of heart complications, the FDA says the drugs pose a greater risk to patients than any potential benefits.
The decades-old drugs are also prescribed for lupus and rheumatoid arthritis. The move follows a string of studies showing the drugs had little benefit and increased chances of harmful side effects.
Trump previously took the drugs preemptively against COVID-19 infection.